<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37257127</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Respiratory Coinfections in Children With SARS-CoV-2.</ArticleTitle><Pagination><StartPage>774</StartPage><EndPage>780</EndPage><MedlinePgn>774-780</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000003981</ELocationID><Abstract><AbstractText Label="BACKGROUND">As the transmission of endemic respiratory pathogens returns to prepandemic levels, understanding the epidemiology of respiratory coinfections in children with SARS-CoV-2 is of increasing importance.</AbstractText><AbstractText Label="METHODS">We performed a retrospective analysis of all pediatric patients 0-21 years of age who had a multiplexed BioFire Respiratory Panel 2.1 test performed at Children's Healthcare of Atlanta, Georgia, from January 1 to December 31, 2021. We determined the proportion of patients with and without SARS-CoV-2 who had respiratory coinfections and performed Poisson regression to determine the likelihood of coinfection and its association with patient age.</AbstractText><AbstractText Label="RESULTS">Of 19,199 respiratory panel tests performed, 1466 (7.64%) were positive for SARS-CoV-2, of which 348 (23.74%) also had coinfection with another pathogen. The most common coinfection was rhino/enterovirus (n = 230, 15.69%), followed by adenovirus (n = 62, 4.23%), and RSV (n = 45, 3.507%). Coinfections with SARS-CoV-2 were most commonly observed in the era of Delta (B.1.617.2) predominance (190, 54.60%), which coincided with periods of peak rhino/enterovirus and RSV transmission. Although coinfections were common among all respiratory pathogens, they were significantly less common with SARS-CoV-2 than other pathogens, with exception of influenza A and B. Children &lt;2 years of age had the highest frequency of coinfection and of detection of any pathogen, including SARS-CoV-2. Among children with SARS-CoV-2, for every 1-year increase in age, the rate of coinfections decreased by 8% (95% CI, 6-9).</AbstractText><AbstractText Label="CONCLUSIONS">Respiratory coinfections were common in children with SARS-CoV-2. Factors associated with the specific pathogen, host, and time period influenced the likelihood of coinfection.</AbstractText><CopyrightInformation>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Westbrook</LastName><ForeName>Adrianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Pediatric Biostatistics Core, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tingyu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Pediatric Biostatistics Core, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhakta</LastName><ForeName>Kushmita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Division of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Wilbur</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostad</LastName><ForeName>Christina A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-8439-0592</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 EB027690</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>C.A.R.’s institution has received funds to conduct clinical research unrelated to this manuscript from the National Institutes of Health, BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Moderna, Novavax, PaxVax, Pfizer, Regeneron, Sanofi-Pasteur. She is co-inventor of patented respiratory syncytial virus vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc. The remaining authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>15</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37257127</ArticleId><ArticleId IdType="pmc">PMC10417240</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000003981</ArticleId><ArticleId IdType="pii">00006454-202309000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). COVID-19 Dashboard.
Available at: https://coronavirus.jhu.edu/map.html. Accessed April 10, 2023.</Citation></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, et al. . Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics. 2021;148:e2021051462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. Am J Transplant. 2021;21:3481–3486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653380</ArticleId><ArticleId IdType="pubmed">34624182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Peci A, Tran V, Guthrie JL, et al. . Prevalence of co-infections with respiratory viruses in individuals investigated for SARS-CoV-2 in Ontario, Canada. Viruses. 2021;13:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831481</ArticleId><ArticleId IdType="pubmed">33477649</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazra A, Collison M, Pisano J, et al. . Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect Control Hosp Epidemiol. 2020;41:1228–1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360954</ArticleId><ArticleId IdType="pubmed">32616098</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, et al. ; COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27:83–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Lim B, Baskaran V, et al. . Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Patel K, Milucky J, et al. ; CDC COVID‐NET Surveillance Team. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022. Influenza Other Respir Viruses. 2023;17:e13107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981874</ArticleId><ArticleId IdType="pubmed">36875205</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Hingrat Q, Bouzid D, Choquet C, et al. . Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses. 2021;15:425–428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189235</ArticleId><ArticleId IdType="pubmed">33817971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekuri S, Szymczak WA, Goldstein DY, et al. . SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study. J Antimicrob Chemother. 2021;76:iii12–iii19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460099</ArticleId><ArticleId IdType="pubmed">34555160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Xing Y, Shi L, et al. . Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics. 2020;146:e20200961.</Citation><ArticleIdList><ArticleId IdType="pubmed">32376725</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang H, Wang F, et al. . Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: a retrospective study. Medicine (Baltim). 2021;100:e24315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982148</ArticleId><ArticleId IdType="pubmed">33725930</ArticleId></ArticleIdList></Reference><Reference><Citation>Garazzino S, Lo Vecchio A, Pierantoni L, et al. ; Italian SITIP-SIP Pediatric Infection Study Group. Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study. Front Pediatr. 2021;9:649358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007917</ArticleId><ArticleId IdType="pubmed">33796491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvares PA. SARS-CoV-2 and respiratory syncytial virus coinfection in hospitalized pediatric patients. Pediatr Infect Dis J. 2021;40:e164–e166.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464015</ArticleId></ArticleIdList></Reference><Reference><Citation>Agathis NT, Patel K, Milucky J, et al. ; CDC COVID-NET Surveillance Team. Codetections of other respiratory viruses among children hospitalized with COVID-19. Pediatrics. 2023;151:e2022059037.</Citation><ArticleIdList><ArticleId IdType="pubmed">36995184</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrick B, Dobson-McKittrick A, Toher D, et al. . Test statistics for comparing two proportions with partially overlapping samples. J Appl Quant Methods. 2015;10:1–14.</Citation></Reference><Reference><Citation>Partiallyoverlapping: Partially Overlapping Samples Tests. R package version 2.0. Version 2.0. 2018. Available at: https://CRAN.R-project.org/package=Partiallyoverlapping</Citation></Reference><Reference><Citation>Lambrou AS, Shirk P, Steele MK, et al. ; Strain Surveillance and Emerging Variants Bioinformatic Working Group. Genomic surveillance for SARS-CoV-2 variants: predominance of the delta (B.1.617.2) and omicron (B.1.1.529) variants - United States, June 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:206–211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8830620</ArticleId><ArticleId IdType="pubmed">35143464</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha R, Avner JR. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. 2021;148:e2021052089.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108234</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab S, Ha Do LA, Clifford V, et al. . Changing epidemiology of respiratory syncytial virus in Australia-Delayed re-emergence in Victoria compared to Western Australia/New South Wales (WA/NSW) after prolonged lock-down for coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73:2365–2366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989588</ArticleId><ArticleId IdType="pubmed">33735388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Quinn J, Pinsky B, et al. . Rates of Co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–2086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschiero MN, Duarte A, Palamim CVC, et al. . Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing. Diagn Microbiol Infect Dis. 2022;102:115576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531239</ArticleId><ArticleId IdType="pubmed">34800846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouafi M, Dubos F, Engelman I, et al. . Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021-2022. J Clin Virol. 2022;153:105221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9233550</ArticleId><ArticleId IdType="pubmed">35777223</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayotte A, Mariani-Kurkdjian P, Boizeau P, et al. . Viral identification using multiplex polymerase chain reaction testing does not reduce antibiotic prescribing in paediatric intensive care units. Microorganisms. 2023;11:884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10143589</ArticleId><ArticleId IdType="pubmed">37110306</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu CLH, Raval M, Schnall JA, et al. . Duration of respiratory and gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and synthesis of data. Pediatr Infect Dis J. 2020;39:e249–e256.</Citation><ArticleIdList><ArticleId IdType="pubmed">32618932</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano AD, Brunkard JM, Boehmer TK, et al. . Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:146–152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9351529</ArticleId><ArticleId IdType="pubmed">35085225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>